HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IgG subclass distribution and relative functional affinity of thyroid microsomal antibodies in postpartum thyroiditis.

Abstract
An association between the development of postpartum hypothyroidism and high levels of IgG1 subclass microsomal (M) antibodies has been reported. Using an assay designed to detect reasonable levels of all the four IgG subclasses, we found no differences in the proportion of each IgG subclass in M antibodies of patients with postpartum hyperthyroidism or hypothyroidism compared with control postpartum patients with M antibodies but no thyroid dysfunction. However the total amount of M antibody of each IgG subclass was elevated above the controls in the patients with thyroid dysfunction. The relative functional affinity of M antibodies did not differ between controls and patients with hypothyroidism but declined 5 and 10-12 months after delivery compared to values at 2 months. These results do not support the suggestion that the amount of IgG1 subclass M antibodies particularly determines the course of postpartum thyroiditis. Rather, the total M antibody level, in all four subclasses, is associated with clinical outcome. Resolution of the disease, despite persisting M antibodies, may occur in part because the relative functional affinity of these antibodies declines after delivery.
AuthorsA P Weetman, H Y Fung, C J Richards, A M McGregor
JournalEuropean journal of clinical investigation (Eur J Clin Invest) Vol. 20 Issue 2 Pg. 133-6 (Apr 1990) ISSN: 0014-2972 [Print] England
PMID2112476 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Immunoglobulin G
Topics
  • Antibody Affinity
  • Autoantibodies (metabolism)
  • Female
  • Humans
  • Immunoglobulin G (classification, metabolism)
  • Microsomes (immunology)
  • Puerperal Disorders (immunology)
  • Thyroid Gland (immunology)
  • Thyroiditis (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: